More than 3,000 at-risk corona patients have so far received the drug Paxlobide, manufactured by Pfizer, to prevent serious illness.
On the other hand, about 30% of those entitled to it are in no hurry to take it due to a variety of reasons and tastes.
The Clalit Health Fund stated that "most of the refusals we encounter are not related to the treatment itself, but probably because the omicron is probably less clinically difficult than others - and people tend to try to transmit the disease themselves, without drug intervention."
The Maccabi Health Fund stated that there are people whose condition is improving and they are no longer interested in the drug.
We also noted that sometimes "the days passed for taking the drug until people went to be tested or the result of the test arrived."
There is also a concern about side effects and drug-drug reactions.
In addition, "some patients believe it is a mild illness and do not feel the need or think they should be treated."
In addition to these, there are people "who refuse medication / vaccines in principle".
Leumit Health Fund stated that about 40 percent of those who refuse the drug are also vaccine refusers, and hence the opposition to the issue.
It was also reported that some people expressed concern about the drug and that the rest indicated that they felt better and did not need it.
Batsheva Lifshitz, an insurer of a "national" health fund that used the drug, expressed her satisfaction.
"Her goal is for the condition not to deteriorate where it should, and she did her job. I felt flu and taste symptoms with bitter in my mouth until with the help of the drug I returned to full activity and everything was fine. We have to believe in our medicine."
The United Health Fund stated that 231 patients were treated with faxloid, while another 90 patients refused.
In terms of reasons for refusal, we noted that "there is concern about the drug, or patients claim that they feel better and do not need it" In addition, some are also vaccine refusers and are not interested in the drug.
Were we wrong?
Fixed!
If you found an error in the article, we'll be happy for you to share it with us